Protein Function Analysis Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۶۹۱-۷۰۵ از ۱۹٬۸۶۰ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Joshua Modellمشاهده پروفایل

دانشیار

Johns Hopkins UniversityUnited States

Joshua Modell is an Associate Professor in the Department of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine. His research focuses on the fundamental biology of CRISPR-Cas systems and their roles in bacterial immunity against bacteriophages. Dr. Modell's research interests lie at the intersection of molecular biology, microbial genetics, and immunology. He investigates how CRISPR systems function during live infections, how they avoid autoimmunity, and how phage biology influences susceptibility to CRISPR attacks. His lab employs an interdisciplinary approach combining molecular biology, next-generation sequencing, functional genomics, biochemistry, bioinformatics, and time-lapse microscopy. The recent publications from the Modell lab reveal a strong focus on CRISPR regulation, anti-CRISPR mechanisms, phage defense strategies, and the evolutionary dynamics of CRISPR systems. The work spans from basic mechanistic insights into Cas9 function and spacer acquisition to understanding how viral recombination and anti-CRISPR proteins influence host-pathogen interactions. These studies are published in top-tier journals such as Nature , Cell , and Cell Reports , reflecting the impact and innovation of the research. Scientific Awards: No scientific awards mentioned in the provided text. Dr. Modell actively mentors graduate and undergraduate students, indicating a strong commitment to training the next generation of scientists. His lab includes multiple graduate students such as Katie King, Joshua Garcia-Colon, Marissa Feeley, Rhett Snyder, and Sarah Voss. While specific grant funding is not listed, the scope and productivity of the research suggest substantial extramural support. The lab operates at the forefront of CRISPR biology, aiming to uncover fundamental principles that can inform the development of next-generation genome-editing technologies. The Modell Lab is an active research group within the Department of Molecular Biology and Genetics at Johns Hopkins University School of Medicine. It uses cutting-edge techniques to study CRISPR immunity in its native biological context, focusing on type II CRISPR systems like Cas9. The lab integrates genetic, genomic, and cellular analyses to explore how CRISPR systems co-evolve with their bacterial hosts and viral predators.

پروفایل رسمی دانشگاه

Emma Denhamمشاهده پروفایل

مدرس ارشد

University of BathUnited Kingdom

Emma Denham is a Senior Lecturer in Microbiology at the University of Bath's Department of Biology and Biochemistry, part of the Centre for Climate Adaptation & Environment Research (CAER). She transitioned to Bath in 2018 from the University of Warwick, where she served as an Assistant Professor. Her research focuses on non-coding RNAs in Bacillus subtilis , exploring their roles in post-transcriptional regulation, biofilm formation, antimicrobial resistance, and metabolic pathways. She investigates how small RNAs (sRNAs) and antisense RNAs modulate bacterial behavior under environmental stress. Education & Career: BSc Biology, University of Leicester PhD in Microbiology, Pirbright Institute (formerly Institute for Animal Health) Postdoctoral Research, Jan Maarten van Dijl's lab (EU consortia on systems/synthetic biology) Research Interests: Emma's lab studies regulatory RNAs' impact on B. subtilis behavior, including biofilm formation, competence, and antibiotic resistance. Notable projects include identifying novel sRNA mechanisms distinct from Gram-negative systems and exploring RNA sponges that regulate the RoxS riboregulator. Collaborative efforts include applying bacterial systems to develop zero-carbon concrete via Engineering and Physical Sciences Research Council (EPSRC) grants (2023). Recent Work Trends: Recent articles highlight mechanisms of bacterial resistance to antiseptics, transcriptome annotation via Rend-seq, and RNA-sponge-mediated regulation. These studies bridge basic microbiology with applied challenges like biocide resistance and sustainable materials. Grants & Collaborations: EPSRC IAA Project: Bacteria-based zero carbon concrete (2023) EU consortia during postdoctoral work Labs & Teams: Leads a microbiology lab at Bath, focusing on interdisciplinary projects combining genomics, systems biology, and synthetic approaches to understand bacterial adaptation and regulatory networks.

پروفایل رسمی دانشگاه

Christina Gertrude Yapمشاهده پروفایل

مدرس ارشد

Monash UniversityAustralia

Christina Gertrude Yap is a Senior Lecturer in Metabolic Medicine at the Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS), Monash University Malaysia. She is actively involved in research, teaching, and academic leadership, with a focus on diabetic nephropathy, metabolic disorders, and medical education. She supervises PhD students and leads multiple research projects in diabetes and obesity. PhD in Biomedical Sciences, Monash University (2012) Graduate Certificate in Higher Education, Monash University (2015) Dr. Yap's research centers on identifying early biomarkers for metabolic syndromes, particularly diabetic nephropathy, with a focus on CYP2E1 and other endogenous molecules. Her work integrates proteomics, metabolomics, and animal models to explore pharmacokinetics, xenobiotic interactions, and translational applications. She also investigates teaching and learning methodologies in medical education. Her recent publications (2021–2025) span diabetes, neuroprotection, obesity, and public health, with a strong emphasis on mechanistic studies and clinical translation. Articles explore hippocampal neuroprotection in diabetic rats, social determinants of obesity, and vaccine mechanisms, reflecting a multidisciplinary approach bridging basic science and public health. Scientific awards include: Best Mention Award, 14th Biological Science Congress (2009) Best Presentation Award, 5th World Congress on Diabetes and Metabolism (2014) First Prize and Best Presentation Award, Monash CSJB Research Week and World Congress on Clinical Trials in Diabetes (2017) Seed Grant Award, Monash University (2024) Dr. Yap has been a PhD supervisor since 2011 and is currently accepting new students. She has secured multiple research grants, including active projects on renal protection in type 2 diabetes and anti-obesity effects of natural compounds. Her leadership roles include coordinating physiology and hematology in the MBBS program and serving on the Student Support Committee. She is a member of the Malaysian Scientific Association and the Malaysian Society of Pharmacology & Physiology. She leads a research team focused on metabolic medicine, utilizing advanced analytical techniques and collaborative networks to advance understanding of diabetes and obesity. Her lab integrates molecular biology, animal models, and clinical data to develop early diagnostic tools and therapeutic strategies.

پروفایل رسمی دانشگاه

Michelle Krogsgaardمشاهده پروفایل

دانشیار

New York UniversityUnited States

Michelle Krogsgaard is an Associate Professor in the Department of Pathology at NYU Grossman School of Medicine, where she leads the Krogsgaard Lab at the Smilow Research Center in New York. Her research focuses on the molecular mechanisms of T-cell receptor (TCR) signaling in the context of cancer immunology, autoimmunity, and immunotherapy development. Research Interests: Dr. Krogsgaard's work lies at the intersection of immunology, biophysics, and structural biology. Her lab investigates how T cells recognize antigens, with a particular emphasis on TCR sensitivity, receptor signaling dynamics, and the structural basis of immune recognition. This includes studying neoantigens, TCR-CD3 complex assembly, and strategies to enhance immunotherapy while minimizing autoimmune side effects. Publication Trends: Her recent publications, appearing in high-impact journals such as Nature , Cell Reports , and PNAS , reflect a strong trajectory in structural immunology and translational cancer research. Themes include TCR engineering, phosphopeptide immunogenicity, mitochondrial influences on immune response, and the balance between antitumor efficacy and autoimmunity. The work combines molecular, structural, and clinical approaches to advance precision immunotherapy. Scientific Awards: No specific awards are listed in the provided text. Advising and Grants: Dr. Krogsgaard leads an active research laboratory and mentors trainees in immunology and cancer research. Her lab has received support from programs such as the Blood Cancer Pilot Grants, which fund translational research in novel immunotherapies. While specific grant amounts and student names are not provided, her extensive publication record and lab leadership indicate a robust program of funded research and academic mentorship. Labs and Teams: The Krogsgaard Lab is based at the Smilow Research Center and employs a multidisciplinary approach, including structural biology, animal models, and human tissue analysis. The team investigates fundamental TCR signaling mechanisms to inform the development of safer and more effective cancer immunotherapies.

پروفایل رسمی دانشگاه

Eva Falchمشاهده پروفایل

استاد

Norwegian University of Science And TechnologyNorway

Eva Falch is a Professor at the Department of Biotechnology and Food Science, Norwegian University of Science and Technology (NTNU). She chairs the Research Council of Norway’s Food and Bioresources Portfolio Board and serves on boards of the European Food Forum and JPI Healthy Diet initiatives. Her academic career includes roles as Vice Dean for Innovation and Education at NTNU. Education: PhD in Biotechnology (NTNU, 2006), Master in Food Science (NMBU), and Bachelor in Food Technology (HiST). Her research focuses on sustainable utilization of marine resources, lipid technology, and food innovation. Key competencies include biotechnology, seafood quality, omega-3 fatty acids, and rest raw material valorization. Research interests emphasize bioeconomy, marine lipid utilization, and cross-industry collaboration. Her work bridges academia and industry, addressing challenges in cardioprotective foods, innovation processes, and student-industry engagement. Recent projects include UP4Food (upcycling side-streams) and OMEGA (fish oil microencapsulation). Publications span food chemistry, marine biology, and biotechnology, with emphasis on seafood processing, protein hydrolysates, and functional ingredients. Her work highlights sustainable practices for waste-to-value conversion in fisheries.

پروفایل رسمی دانشگاه

Jeffrey W. Brittonمشاهده پروفایل

استاد

Mayo Clinic College of Medicine and ScienceUnited States

Jeffrey W. Britton, M.D. is a Professor of Neurology at Mayo Clinic in Rochester, Minnesota, serving as Chair of the Division of Epilepsy and Program Director of the Epilepsy Fellowship. His clinical and academic work is centered within the Department of Neurology at Mayo Clinic College of Medicine and Science, with expertise in EEG monitoring and autoimmune neurology. His educational trajectory includes a B.S. in Biology (with distinction) from the University of Iowa (1985), an M.D. from Carver College of Medicine (1989), neurology residency (1993), and Clinical Neurophysiology fellowship (EEG/Epilepsy) at Mayo Clinic (1999). Britton's research specializes in autoimmune epilepsies and encephalopathies , particularly LGI1 antibody encephalitis, alongside cardiopulmonary effects of seizures , neuromodulation therapies , and innovations in epilepsy diagnostics . His work integrates clinical neurophysiology with neurology education, frequently examining EEG applications in autoimmune contexts. Recent publications (2016-2025) reveal a pronounced focus on autoimmune epilepsy mechanisms and stereo-EEG safety. Key trends include multicenter analyses of antibody-mediated encephalitis outcomes, seizure-related fall risks, and neuromodulation techniques, reflecting his leadership in translating neuroimmunology research into clinical practice. Notable honors include: Fellowships in American Epilepsy Society (2016), American Academy of Neurology (2016), American Clinical Neurophysiology Society, and American Neurological Association (2012) Excellence in Teaching Awards from Mayo Medical School (2004, 2005) Henry Woltman Award (Mayo Graduate School of Medicine, 1993) Magna cum laude citation for educational exhibits (Radiological Society of North America, 2020) Britton has trained neurology residents and fellows for decades while co-founding the Epilepsy-Neuroradiology Collaborative Research Meeting (2013-present). His grant-related activity includes serving as Epilepsy Foundation Grant Reviewer since 2013, though specific funded projects aren't detailed. He leads the Autoimmune Epilepsy Diagnosis Task Force (International League Against Epilepsy) and co-founded Mayo Clinic's Epilepsy Fellowship program infrastructure. Current initiatives include the Resident and Fellow Committee (American Clinical Neurophysiology Society) and American Board of Clinical Neurophysiology leadership (President since 2018).

پروفایل رسمی دانشگاه

Allan Rasmussonمشاهده پروفایل

استاد

Lund UniversitySweden

Allan Rasmusson is a Professor in the Department of Biology at Lund University, Faculty of Science, specializing in Plant Biology and Molecular Biosciences. His research spans plant-fungal interactions, mitochondrial function, redox biology, and paleophysiology. He leads multiple active research projects and supervises graduate students, while also managing shared infrastructure such as the departmental greenhouses. Research Interests: Allan Rasmusson's research is highly interdisciplinary, focusing on: Plant-Trichoderma interactions for biocontrol and biostimulation in crops like sugar beet, quinoa, and cañahua. Mitochondrial function, including electron transport chain assembly and retrograde signaling in Arabidopsis thaliana and maize. Redox biology and plant metabolism under different nitrogen sources. Paleophysiology, investigating how ancient plant lineages survived mass extinctions through studies of fossil pollen and plant physiology under paleomimetic conditions. Recent Research Trends: His recent publications (2022–2024) reflect a strong focus on both molecular plant biology and paleobotany. Key themes include mitochondrial translation initiation, cytochrome c oxidase assembly, plant defense against pathogens like Peronospora , and the role of abnormal pollen in end-Triassic extinction events. These works appear in high-impact journals such as Science , Plant Physiology , and Palaeogeography, Palaeoclimatology, Palaeoecology . Scientific Awards and Funding: Funded by the Knut and Alice Wallenberg Foundation for research on ancient and modern plant comparisons. Advising and Grants: Allan Rasmusson actively supervises doctoral students and serves as Principal Investigator (PI) on multiple research projects. He is currently supervising V. D. Palma Encinas and co-supervising H. C. Tran. His projects include biocontrol using Trichoderma , mitochondrial retrograde signaling, and paleophysiogenomics. He also contributes to educational grants through textbook development and curriculum design. Labs and Teams: He is a co-manager of the Department of Biology’s greenhouse infrastructure at Lund University, supporting experimental plant growth. He collaborates with researchers from SLU, DLF Research AB, UMSA-La Paz (Bolivia), Naturhistoriska Riksmuseet, Linnaeus University, Copenhagen University, CSU-San Marcos, and Warsaw University.

پروفایل رسمی دانشگاه

Jonathan Klassenمشاهده پروفایل

دانشیار

University of ConnecticutUnited States

Jonathan Klassen is an Associate Professor in the Department of Molecular and Cell Biology / Microbiology at the University of Connecticut . His research focuses on microbial community ecology, particularly using the fungus-growing ant symbiosis as a model system to study the evolution of microbial interaction networks. He couples genomics and chemical biology to understand molecular mechanisms in symbiosis and explore drug discovery opportunities. PhD : Microbiology and Biotechnology, University of Alberta Postdoctoral Study : Bacteriology, University of Wisconsin-Madison His work spans microbial ecology, symbiosis, secondary metabolite discovery, and comparative genomics. Recent publications highlight studies on microbial exclusion dynamics in ant symbiosis, ITS2 metabarcode biases, and chemical defense mechanisms in insect-associated microbes. Scientific Awards : “Highly Accessed” article in BMC Genomics (2012) Contact : Email: jonathan.klassen@uconn.edu Phone: 860-486-6890 Lab: @klassenlab

پروفایل رسمی دانشگاه

Lucy Gloverمشاهده پروفایل

پژوهشگر

Pasteur InstituteFrance

Lucy Glover is a Researcher and Group Leader of the Trypanosome Molecular Biology laboratory at the Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France. She joined the institute in March 2016 as a G5 group leader, focusing on the molecular mechanisms of antigenic variation and DNA repair in Trypanosoma brucei , the causative agent of Human African Trypanosomiasis. Her research integrates molecular, biochemical, and high-throughput approaches to study DNA recombination and immune evasion. Institut Pasteur, Paris (2016–Present) PhD, London School of Hygiene and Tropical Medicine Her research interests center on antigenic variation , DNA repair , and homologous recombination in trypanosomes. She investigates how DNA double-strand breaks influence variant surface glycoprotein (VSG) switching, a critical process for parasite survival in the host. Her lab uses advanced techniques such as RIT-seq, phosphoproteomics, and CRISPR-based tools to dissect these mechanisms at the molecular level. The recent publications of Lucy Glover span molecular parasitology, DNA damage response, and diagnostic development. Key themes include the role of the MRN complex in DNA repair, phosphoproteomic profiling of DNA damage responses, and the design of CRISPR-based diagnostics for HAT. Her work reveals how chromosomal context influences repair pathways and antigenic variation, contributing to a deeper understanding of parasite biology. While no formal scientific awards are listed in the provided text, her contributions are evident through high-impact publications and leadership in collaborative research projects. Lucy Glover advises several PhD and postdoctoral researchers, including Emilia MacLaughlin, Nuria Sima Teruel, and Alix Thivolle. Her lab is supported by institutional initiatives such as LabEx IBEID and transversal drug discovery programs. She collaborates with teams working on host-pathogen interactions, genomics, and infectious disease epidemiology. Her laboratory is part of the Department of Parasites and Insect Vectors and participates in departmental retreats and seminars. The team includes post-docs, research engineers, and administrative staff, reflecting a collaborative and interdisciplinary research environment focused on combating neglected tropical diseases.

پروفایل رسمی دانشگاه

Jae Ho Leeمشاهده پروفایل

پژوهشگر ارشد

Newcastle UniversityUnited Kingdom

Dr. Jae Ho Lee is a research scientist at Newcastle University specializing in stem cell biology and cancer research, with significant publications between 2006-2010 primarily in collaboration with Professor Karim Nayernia and colleagues including Dr. Ingrid Ehrmann and Professor David Elliott. His work bridges molecular oncology, reproductive biology, and regenerative medicine through investigation of stem cell mechanisms in germ cell development and tumorigenesis. His core research examines stem cell plasticity in cancer and reproduction, focusing on Piwil2 protein functions in breast cancer stem cell proliferation/antiapoptosis, derivation of germ cells from bone marrow stem cells, and spermatogonial stem cell regulation. Key contributions include demonstrating Piwil2's role in Stat3/Bcl-XL-mediated tumor survival, in vitro production of functional male gametes from embryonic stem cells, and transdifferentiation pathways between somatic and germ cells. Analysis of his 2006-2010 publications reveals consistent exploration of molecular intersections between stem cell self-renewal and oncogenesis, with emphasis on Piwil2 as a regulatory hub. His work demonstrates translational potential for infertility treatments through germ cell derivation techniques and identifies apoptosis pathways as therapeutic targets in breast cancer. No scientific awards were documented in the source materials. While specific student mentorship isn't listed, his collaborative publications with senior researchers indicate active laboratory leadership in stem cell projects. The consistent co-authorship with Professor Nayernia suggests participation in grant-funded research programs focused on germ cell biology and cancer stem cells, though exact funding sources remain unspecified.

پروفایل رسمی دانشگاه

Christian Freundمشاهده پروفایل

استاد

Heidelberg UniversityGermany

Christian Freund is Professor of Protein Biochemistry at the Institute for Chemistry & Biochemistry, Freie Universität Berlin, holding this W2 professorship since 2011. He serves as Coordinator of the FU Berlin-UCSF Collaborative Initiative and Founding Member/Vice-chair of the DFG Collaborative Research Centre SFB/TRR 186 on Molecular Switches in Cellular Signal Transmission, leading interdisciplinary research across Berlin and Heidelberg institutions. His academic foundation includes Chemistry studies at Heinrich-Heine-Universität Düsseldorf (1983-1986) and Ludwig-Maximilians-Universität München (1986-1989), followed by a PhD in Structural Biology at the Max-Planck-Institute of Biochemistry (1994) and Habilitation in Biochemistry at Freie Universität Berlin (2005). Freund's research integrates structural biology, biophysics, and immunology to investigate molecular mechanisms of antigen presentation and cellular signaling. His work centers on MHC class II dynamics, protein conformational switches, and nanoscale organization of signaling complexes, employing NMR spectroscopy, quantitative proteomics, and molecular engineering to dissect immune recognition pathways and neuronal signaling mechanisms. Analysis of his 2010-2019 publications reveals consistent focus on MHC-mediated antigen presentation (60% of works), with significant contributions to understanding peptide exchange dynamics and HLA-DM editing functions. Secondary research streams explore synaptic protein networks (25%) and T cell signaling machinery (15%), demonstrating methodological breadth across structural biology, proteomics, and cell biological approaches. His scientific recognition includes: Biofuture award from the German Ministry of Education and Research (1999) Swiss National Funds Post-doctoral Scholarship (1997) Innovationswettbewerb Medizintechnik grant (2009) As research group leader at Leibniz-Institute of Molecular Pharmacology (2000-2011) and current FU Berlin professor, Freund has secured major collaborative funding through DFG SFB/TRR 186 and the UCSF partnership. His mentorship spans postdoctoral fellows at Harvard/Dana-Farber and Leibniz-Institute, with current supervision of graduate students in the Berlin biochemistry program. Freund directs a research group within FU Berlin's Institute for Chemistry & Biochemistry, operating as core component of SFB/TRR 186. His laboratory maintains active collaborations with UCSF's QBI (Nevan Krogan) and Heidelberg-based structural biology teams, utilizing advanced NMR, cryo-EM, and single-molecule imaging facilities across the Berlin-Heidelberg research alliance.

پروفایل رسمی دانشگاه

Nediljko Budisaمشاهده پروفایل

استاد

University of ManitobaCanada

Nediljko Budisa is a Professor and Tier 1 Canada Research Chair in Chemical Synthetic Biology and Xenobiology at the University of Manitoba's Faculty of Science, Department of Chemistry. His research program focuses on expanding the fundamental biochemical capabilities of living systems through genetic code engineering and synthetic biology approaches. Dr. Budisa's research spans multiple cutting-edge areas in synthetic biology, with particular emphasis on genetic code expansion , non-canonical amino acid incorporation , and protein engineering . His laboratory employs both classical biochemical techniques and advanced computational methods to develop orthogonal translation systems, engineer novel enzymes, and create synthetic cells with expanded biochemical repertoires. His work bridges chemistry, biology, and engineering to address fundamental questions about life processes while developing practical applications in biotechnology and medicine. Analysis of Dr. Budisa's publication record reveals a consistent trajectory of innovation in genetic code engineering, with recent work increasingly integrating machine learning approaches for protein design. His research spans from fundamental studies of protein structure-function relationships to applied research in metabolic engineering and antiviral strategies, demonstrating the versatility of synthetic biology approaches. Tier 1 Canada Research Chair in Chemical Synthetic Biology and Xenobiology Dr. Budisa leads an active research program supported by his Canada Research Chair position, with extensive collaborations across Canada and internationally. His work has resulted in numerous patents and commercial applications in biotechnology. He actively participates in the synthetic biology community through initiatives like Prairie iGEM BioExM and has delivered public lectures on methodological challenges in expanded genetic code research. His research is conducted through the Chemical Synthetic Biology and Xenobiology laboratory at the University of Manitoba, where his team explores the social, cultural, educational, ethical and philosophical aspects of synthetic biology alongside technical innovations, reflecting a comprehensive approach to advancing this transformative field.

پروفایل رسمی دانشگاه

Kate Bakerمشاهده پروفایل

استادیار

University of CambridgeUnited Kingdom

Dr. Kate Baker is a Programme Leader at the MRC Cognition and Brain Sciences Unit, University of Cambridge, and holds joint appointments as Assistant Professor of Clinical Genetics in the Department of Pathology and Honorary Consultant at Cambridge University Hospital. Her research bridges clinical genetics and cognitive neuroscience, focusing on neurodevelopmental disorders of genetic origin. She leads the Genomic Disorders and Cognitive Development group and the BINGO project, investigating how genetic variations impact neural systems and cognitive abilities like communication and social interaction. Her work emphasizes translational genomic medicine, aiming to improve evidence-based, person-centered care for individuals with intellectual disabilities. Research spans neurogenetics, cognitive phenotyping, synaptic function, and developmental trajectories. Publications consistently explore genotype-phenotype correlations in disorders like SYT1, ZDHHC9, and DDX3X, with recent work expanding into pandemic impacts on neurogenetic families. Key funders include the Baily Thomas Charitable Trust, NIHR Cambridge Biomedical Research Centre, and Great Ormond Street Hospital Charity. No awards are documented in available sources.

پروفایل رسمی دانشگاه

Wilfried Andlauerمشاهده پروفایل

استاد

Western Switzerland University of Applied SciencesSwitzerland

Wilfried Andlauer is a Professor at the Institute of Life Sciences within HES-SO Valais-Wallis School of Engineering. His research focuses on bioactive compounds , non-thermal food processing , and bioavailability studies , particularly in agricultural by-products like grape cane, walnut press cake, and Spirulina algae. He has developed advanced methods for solid-state fermentation , cold plasma decontamination , and bioactives fingerprinting . Key projects include optimizing microwave-assisted extraction for stilbenoids, analyzing iron absorption from insect flour , and developing microfluidic antioxidant assays . His work integrates nutraceutical research with practical applications in food safety and sustainable processing . Collaborations span Switzerland and Asia , with expertise in analytical chemistry and bioprocessing .

پروفایل رسمی دانشگاه

Laura M.K. Dassamaمشاهده پروفایل

استادیار

Stanford UniversityUnited States

Laura Dassama is an Assistant Professor at Stanford University with appointments in both the Department of Chemistry and Department of Microbiology & Immunology . She is actively affiliated with multiple interdisciplinary institutes including Bio-X , SPARK at Stanford , MCHRI , Sarafan ChEM-H , and Wu Tsai Neurosciences Institute . PhD in Biochemistry and Molecular Biology from Pennsylvania State University (2013) Postdoctoral training at Northwestern University (Molecular Biosciences, 2017) Research Associate position at Boston Children's Hospital/Harvard Medical School/Dana-Farber Cancer Institute (2018) Laboratory research focuses on chemical biology approaches to understand biomolecular interactions, particularly bacterial lipid trafficking and targeted protein degradation . Key methodologies include bioinformatic analyses , structural studies , and machine learning algorithms like SLiPP for lipid-binding pocket prediction. Recent publications emphasize antimicrobial resistance challenges and opportunities, protein delivery systems for erythroid cells, and structure-function relationships in lipid transport proteins. These studies demonstrate innovative approaches to address therapeutic limitations through chemical biology tools and interdisciplinary methods . MAC3 Impact Philanthropies Faculty Fellow (2023-2025) Terman Faculty Fellowship (2022-2025, 2018-2021) Hellman Faculty Scholar (2019-2020) Gabilan Junior Faculty Fellowship (2018-2021) Active advisor to multiple PhD candidates and postdoctoral researchers , with formal advising roles in Biophysics , Cancer Biology , and Microbiology & Immunology graduate programs. Laboratory located at Rm. W215 ChEM-H/Neuro Research Complex .

پروفایل رسمی دانشگاه